BC
EBS icon

Barrett & Company’s Emergent Biosolutions EBS Stock Holding History

Barrett & Company’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.47K Buy
+175
New +$1.46K ﹤0.01% 646

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Barrett & Company's EBS Position: Q2 2026 in Review

Barrett & Company opened a new position in Emergent Biosolutions (EBS) in Q2 2026: 175 shares worth $1.47K. The stake represents ﹤0.01% of the portfolio and ranks #646 among its holdings.

195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Barrett & Company held 175 shares of Emergent Biosolutions worth $1.47K as of Q2 2026.
  • Emergent Biosolutions was a new Barrett & Company position in Q2 2026.
  • Emergent Biosolutions made up ﹤0.01% of Barrett & Company's portfolio in Q2 2026, its #646 holding.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Barrett & Company's 13F filing for Q2 2026, filed 24 Jul 2026.